For citations:
Markov V.A., Duplyakov D.V., Konstantinov S.L., Klein G.V., Aksentev S.B., Platonov D.Yu., Vyshlov E.V., Ponomarev E.A., Rabinovich R.M., Makarov E.L., Kulibaba E.V., Yunevich D.S., Kritskaia O.V., Baranov E.A., Talibov O.B., Gerasimets E.A. Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1. Russian Journal of Cardiology. 2018;(11):110-116. (In Russ.) https://doi.org/10.15829/1560-4071-2018-11-110-116
Email this article 